Clinical

Real world data has reported the comparison outcomes between ranibizumab (Lucentis) and aflibercept (Eylea) for Diabetic Macular Edema (DME)

A clinical research report, published in the journal Ophthalmology, has found that two leading anti-VEGF treatments had shown beneficial outcomes for DME in a study… Read More »Real world data has reported the comparison outcomes between ranibizumab (Lucentis) and aflibercept (Eylea) for Diabetic Macular Edema (DME)

Phase II study results on intravitreal (IVT) pegcetacoplan (a synthetic cyclic peptide) for the treatment of geographic atrophy (GA) secondary to ARMD

A Phase II study investigating intravitreal pegcetacoplan for the treatment of geographic atrophy (GA), secondary to age-related macular degeneration (AMD), has announced the reporting of… Read More »Phase II study results on intravitreal (IVT) pegcetacoplan (a synthetic cyclic peptide) for the treatment of geographic atrophy (GA) secondary to ARMD

A systematic review of registered trials in ClinicalTrials.gov shows the characteristics of geographic atrophy treatment trials

Researchers at the Scheie Eye Institute, University of Pennsylvania, Philadelphia, has published a systematic review to assess the key design characteristics of geographic atrophy (GA)… Read More »A systematic review of registered trials in ClinicalTrials.gov shows the characteristics of geographic atrophy treatment trials

A prospective study of 5,000 participants indicates that a Mediterranean diet has a 41% reduced risk of incidence of advanced AMD

A combination of two European population-based prospective cohorts has carried out the investigation on the adherence to a Mediterranean diet (“MeDi”).  The adherence to the… Read More »A prospective study of 5,000 participants indicates that a Mediterranean diet has a 41% reduced risk of incidence of advanced AMD